Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
about
The Regulatory Networks That Control Clostridium difficile Toxin SynthesisClostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.Clostridium difficile and the microbiotaUsing phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.Procalcitonin levels associate with severity of Clostridium difficile infectionImpacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children.Molecular epidemiology of Clostridium difficile at a medical center in Taiwan: persistence of genetically clustering of A⁻B⁺ isolates and increase of A⁺B⁺ isolates.Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdCCefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strainsGrowth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study.Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 StrainsClostridium difficile ribotype does not predict severe infection.NAP1 strain type predicts outcomes from Clostridium difficile infection.Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseaseImportance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.Clostridial binary toxins: iota and C2 family portraits.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.Investigation of toxin gene diversity and antimicrobial resistance of Clostridium difficile strains.Development and optimization of a high-throughput assay to measure neutralizing antibodies against Clostridium difficile binary toxin.Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.Role of binary toxin in the outcome of Clostridium difficile infection in a non-027 ribotype setting.Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain.Measuring the impact of Clostridium difficile Infection with the NAP1 strain on severity and mortality.colitis and zoonotic origins-a narrative reviewPathogenicity locus determinants and toxinotyping of isolates recovered from Iranian patients
P2860
Q26748946-35CB974E-F39B-4437-B1BF-AED2BAB6C64BQ33728296-F256A1CE-7C09-42E9-A55B-AF944A80F045Q34311594-27E492E1-EE92-465F-91B0-CC646AECF5F0Q34598906-EBF39FE3-4A0F-42DE-A02D-A800466703C0Q34625689-876409B6-24E5-418A-8AC2-287B207C266CQ34698807-4E7863A5-6E29-41DD-B43E-C277289468C8Q35014457-EBC310E1-CEDF-4D0A-B773-67AA45BC2800Q35036237-249F61A5-1606-4FE5-BB57-A1347C35CD2AQ35193183-C505A5EA-0273-4C32-90E1-936DF3152E49Q35599031-4429C704-58EB-47F4-B177-0D12C58335FCQ35914081-96236819-B161-446A-9C94-C5C491533178Q36123790-A348CD28-DE21-4DD0-AF0D-4B2CD100B74BQ36190012-D27BBBE8-C479-4C85-9081-84547237F9D9Q36261170-31557BC4-3886-4BDA-90F6-E3457D6E2856Q36408941-91AABAC7-B5C8-4E20-AAE8-D107BC23D0AAQ36420815-93B2A9DA-5826-45D2-BACB-D5F62B8A7A5AQ37014160-C47CDC7B-8674-493E-8612-493DFA32FBA8Q37395323-BC44BB8E-3B7A-4A9B-96DB-5DBB14C08026Q38037529-9552C44A-6F75-4ABA-82A1-0ECADB1A0675Q38765888-576F84BA-2C02-4D5D-9546-3E038B9A9E61Q39000863-8A4D1339-DAEE-4502-AC16-50330F467289Q39155301-8C29AC99-2908-4634-8C28-20F2930DC579Q39539884-538CD194-7FD9-4A86-A98E-7DB9E7C9DCFDQ39665226-4407479B-97C1-4D1C-89E5-A81800EB4FEBQ40620301-C0D43A9E-4B06-47CE-8F44-778578A132D1Q40652971-B582A4EC-7B47-4BAE-A858-1EB42BC6D344Q40788336-D58ECA9B-10F5-49B2-86B9-F0AA0913EB38Q41650253-0C8FEB11-72B0-47CD-BE12-3731D50FB5BAQ42220493-D6C399C1-C343-4101-8238-A205E98E149BQ43063934-44870D1F-C8E1-416B-8A2E-9652593DEC5CQ56559610-F91C2544-42F2-4C32-82C7-75B088BCD416Q58803557-FF71C758-6A41-4834-81D8-49D9329C25A7
P2860
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@en
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@nl
type
label
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@en
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@nl
prefLabel
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@en
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@nl
P1433
P1476
Lack of association of tcdC ty ...... xigenic Clostridium difficile.
@en
P2093
Gary L French
P304
P356
10.1016/J.JINF.2011.03.001
P577
2011-03-21T00:00:00Z